3 weeks on the job at Telfer and not one ounce of news on how this rig on steroids is performing.Surprised the share price isnt much lower.No news is bad news.Iam discusted.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress